학술논문
Nrf2 Null Mice Are Deficient in CD169+ Macrophages, Associated with Impaired Erythroid Response and Delayed Recovery from Acute Blood Loss
Document Type
Article
Author
Source
Blood; November 2019, Vol. 134 Issue: Supplement 1 p1038-1038, 1p
Subject
Language
ISSN
00064971; 15280020
Abstract
Ofori-Acquah: Shire Human Genetic Therapies Inc: Other: Financial Relationship. Kato:Bayer: Research Funding; Novartis, Global Blood Therapeutics: Consultancy, Research Funding.